Open | $0.631 |
Close | $0.640 |
Volume / Avg. | 24.807K / 515.540K |
Day Range | 0.620 - 0.680 |
52 Wk Range | 0.365 - 1.500 |
Market Cap | $5.448M |
P/E Ratio | 0.350 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 49 |
Short Interest | % |
Days to Cover | 3.41 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Exicure (NASDAQ: XCUR) through any online brokerage.
Other companies in Exicure’s space includes: Alzamend Neuro (NASDAQ:ALZN), Virios Therapeutics (NASDAQ:VIRI), Tharimmune (NASDAQ:THAR), Synaptogenix (NASDAQ:SNPX) and Finch Therapeutics Gr (NASDAQ:FNCH).
The latest price target for Exicure (NASDAQ: XCUR) was reported by Chardan Capital on Tuesday, August 16, 2022. The analyst firm set a price target for 2.00 expecting XCUR to rise to within 12 months (a possible 217.46% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Exicure (NASDAQ: XCUR) is $0.63 last updated March 18, 2024 at 8:41 AM EDT.
There are no upcoming dividends for Exicure.
Exicure’s Q3 earnings are confirmed for Monday, April 1, 2024.
There is no upcoming split for Exicure.
Exicure is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.